[
  {
    "ts": null,
    "headline": "BeOne Medicines: Brukinsa Momentum And Pipeline Catalysts Justify Its Premium",
    "summary": "Discover why BeOne Medicines (BEIGF) is a strong Buy with growth driven by Brukinsa, Tevimbra, and a promising oncology pipeline.",
    "url": "https://finnhub.io/api/news?id=48d2aa2b51419359ce3895ab9e676565b220c2273b8f4d8975dc223b1df171fe",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750071968,
      "headline": "BeOne Medicines: Brukinsa Momentum And Pipeline Catalysts Justify Its Premium",
      "id": 135305491,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2160714898/image_2160714898.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Discover why BeOne Medicines (BEIGF) is a strong Buy with growth driven by Brukinsa, Tevimbra, and a promising oncology pipeline.",
      "url": "https://finnhub.io/api/news?id=48d2aa2b51419359ce3895ab9e676565b220c2273b8f4d8975dc223b1df171fe"
    }
  },
  {
    "ts": null,
    "headline": "EHA 2025: Regeneron’s Lynozyfic with Amgen’s Kyprolis combo emerges for R/R MM",
    "summary": "Lynozyfic’s global sales are projected to reach $707 million by 2031.",
    "url": "https://finnhub.io/api/news?id=462c3debc4a0ab7694021ac22831712b8a22ad338f9529618750b0b797bad9af",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750070215,
      "headline": "EHA 2025: Regeneron’s Lynozyfic with Amgen’s Kyprolis combo emerges for R/R MM",
      "id": 135303052,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Lynozyfic’s global sales are projected to reach $707 million by 2031.",
      "url": "https://finnhub.io/api/news?id=462c3debc4a0ab7694021ac22831712b8a22ad338f9529618750b0b797bad9af"
    }
  },
  {
    "ts": null,
    "headline": "AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY",
    "summary": "THOUSAND OAKS - Amgen announced the launch of The Making of a Heart Attack, a documentary that sheds light on the cardiovascular disease crisis in the United States, where every 40 seconds someone...",
    "url": "https://finnhub.io/api/news?id=68cf407a77ed423271a767fa7e9a2f294d523bd00348040564494d3b9ad96be1",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750065378,
      "headline": "AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY",
      "id": 135300749,
      "image": "",
      "related": "AMGN",
      "source": "Finnhub",
      "summary": "THOUSAND OAKS - Amgen announced the launch of The Making of a Heart Attack, a documentary that sheds light on the cardiovascular disease crisis in the United States, where every 40 seconds someone...",
      "url": "https://finnhub.io/api/news?id=68cf407a77ed423271a767fa7e9a2f294d523bd00348040564494d3b9ad96be1"
    }
  }
]